AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Frankenfeld, C. L
Right arrow Articles by Ward, M. H
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frankenfeld, C. L
Right arrow Articles by Ward, M. H
Agricola
Right arrow Articles by Frankenfeld, C. L
Right arrow Articles by Ward, M. H
American Journal of Clinical Nutrition, Vol. 87, No. 5, 1439-1445, May 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Dietary flavonoid intake and non-Hodgkin lymphoma risk1,2,3

Cara L Frankenfeld, James R Cerhan, Wendy Cozen, Scott Davis, Maryjean Schenk, Lindsay M Morton, Patricia Hartge and Mary H Ward

1 From the Division of Cancer, Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (CLF, LMM, PH, and MHW); the Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN (JRC); the Keck School of Medicine, University of Southern California, Los Angeles, CA (WC); the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, and the University of Washington School of Public Health and Community Medicine, Seattle, WA (SD); the Department of Family Medicine, Wayne State University, and the Karmanos Cancer Institute, Detroit, MI (MS)

Background: The role of dietary factors in non-Hodgkin lymphoma (NHL) risk is not yet well understood. Dietary flavonoids are polyphenolic compounds proposed to be anticarcinogenic. Flavonoids are well-characterized antioxidants and metal chelators, and certain flavonoids exhibit antiproliferative and antiestrogenic effects.

Objective: We aimed to evaluate the hypothesis that higher flavonoid intake is associated with lower NHL risk.

Design: During 1998–2000, we identified incident NHL cases aged 20–74 y from 4 US Surveillance, Epidemiology, and End Results cancer registries. Controls without history of NHL were selected by random-digit dialing or from Medicare files and frequency-matched to cases by age, center, race, and sex. Using 3 recently developed US Department of Agriculture nutrient-specific databases, flavonoid intake was estimated from participant responses to a 117-item food-frequency questionnaire (n = 466 cases and 390 controls). NHL risk in relation to flavonoid intake in quartiles was evaluated after adjustment for age, sex, registry, education, NHL family history, and energy intake.

Results: Higher total flavonoid intake was significantly associated with lower risk of NHL (P for trend < 0.01): a 47% lower risk in the highest quartile of intake than in the lowest (95% CI: 31%, 73%). Higher intakes of flavonols, epicatechins, anthocyanidins, and proanthocyanidins were each significantly associated with decreased NHL risk. Similar patterns of risk were observed for the major NHL subtypes—diffuse large B-cell lymphoma (n = 167) and follicular lymphoma (n = 146).

Conclusion: A higher intake of flavonoids, dietary components with several putative anticarcinogenic activities, may be associated with lower NHL risk.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition